Mostrar el registro sencillo del ítem

dc.contributor.author
Alonso, Daniel Fernando  
dc.contributor.author
Vázquez, Ana María  
dc.contributor.author
Alonso, Daniel Fernando  
dc.contributor.author
Macías, Amparo  
dc.date.available
2015-12-28T17:59:57Z  
dc.date.issued
2013-02-26  
dc.identifier.citation
Alonso, Daniel Fernando; Vázquez, Ana María; Alonso, Daniel Fernando; Macías, Amparo; Anti-idiotype antibodies in cancer treatment; Frontiers Media S.A.; Frontiers in Oncology; 3; 26-2-2013; 1  
dc.identifier.issn
2234-943X  
dc.identifier.uri
http://hdl.handle.net/11336/3241  
dc.description.abstract
Anti-idiotype antibodies (anti-Id Abs) are antibodies to idiotopes that are located in the variable region, including the antigen binding site, of another antibody. When the last is the case, these anti-Id Abs can act as surrogates of the original antigen. The capability of anti-Id Abs to modulate the immune response has been the basis for the development of anti-Id vaccines against different antigens, including tumor-associated antigens. Over the years, its use in cancer has been demonstrated as effective and promising.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Frontiers Media S.A.  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Anti-Idiotype Antibodies  
dc.subject
Cancer Treatment  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Oncología  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Anti-idiotype antibodies in cancer treatment  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2016-03-30 10:35:44.97925-03  
dc.journal.volume
3  
dc.journal.pagination
1  
dc.journal.pais
Suiza  
dc.journal.ciudad
Lausana  
dc.conicet.avisoEditorial
This Document is Protected by copyright and was first published by Frontiers. All rights reserved. it is reproduced with permission  
dc.description.fil
Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Vázquez, Ana María. No especifíca;  
dc.description.fil
Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Macías, Amparo. No especifíca;  
dc.journal.title
Frontiers in Oncology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fonc.2013.00037/full  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fonc.2013.00037  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581801/  

Archivos asociados
Thumbnail
 
Tamaño: 277.1Kb
Formato: PDF
.